Clinical Trial Update: Radiolabeled TSPO Targeted Molecular Probe in Alzheimer's Disease.

View source ↗

Summary

A radiolabeled TSPO-targeted molecular probe is being studied in Alzheimer's disease, and the trial status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Radiolabeled TSPO Targeted Molecular Probe

Snippet

Sponsor: Nanjing First Hospital, Nanjing Medical University | Conditions: Alzheimer's Disease (AD) | Status: NOT_YET_RECRUITING